Pivotal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pivotal Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10652
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pivotal Therapeutics Inc (Pivotal Therapeutics) is a pharmaceutical company that develops and markets Omega-3 based therapies and therapeutic products for cardiovascular disorders. The company offers products such as VASCAZEN, a medical food formulated for the dietary management of an Omega-3 deficiency in cardiovascular patients. It’s OMAZEN, a formulation which offers Omega-3 for the maintenance of good health. Pivotal Therapeutics collaborates with various companies and researchers to develop and promote new products in the area of cardiovascular disease. The company operates through its offices in Boca Raton, the US; and Woodbridge, Canada. Pivotal Therapeutics is headquartered in Woodbridge, Ontario, Canada.

Pivotal Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Pivotal Therapeutics Forms Joint Venture with ACGT 10
Equity Offering 11
Pivotal Therapeutics to Raise USD1.2 Million in Private Placement of Shares 11
Pivotal Therapeutics Raised USD2.5 Million in Private Placement of Units 12
Pivotal Therapeutics Completes Second Tranche Of Private Placement Of Units For US$3.2 Million 13
Debt Offering 14
Pivotal Therapeutics Raised USD1.5 Million in Private Placement of Units 14
Pivotal Therapeutics Inc – Key Competitors 15
Pivotal Therapeutics Inc – Key Employees 16
Pivotal Therapeutics Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pivotal Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pivotal Therapeutics Forms Joint Venture with ACGT 10
Pivotal Therapeutics to Raise USD1.2 Million in Private Placement of Shares 11
Pivotal Therapeutics Raised USD2.5 Million in Private Placement of Units 12
Pivotal Therapeutics Completes Second Tranche Of Private Placement Of Units For US$3.2 Million 13
Pivotal Therapeutics Raised USD1.5 Million in Private Placement of Units 14
Pivotal Therapeutics Inc, Key Competitors 15
Pivotal Therapeutics Inc, Key Employees 16
Pivotal Therapeutics Inc, Other Locations 17

List of Figures
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pivotal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Pivotal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Uni-President China Holdings Ltd.:戦略・SWOT・企業財務分析
    Uni-President China Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Uni-President China Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • City Utilities of Springfield:企業の戦略的SWOT分析
    City Utilities of Springfield - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Formation Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Formation Biologics Inc (Formation Biologics), formerly AvidBiologics Inc is a clinical stage pharmaceutical company that develops biologics and antibody-drug conjugates (ADCs) with selective anti-tumor properties for the treatment of cancer and rare diseases. The company’s pipeline product …
  • Endeavour Mining Corporation:企業のM&A・事業提携・投資動向
    Endeavour Mining Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Endeavour Mining Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Corgenix Medical Corp-医療機器分野:企業M&A・提携分析
    Summary Corgenix Medical Corp (Corgenix), a subsidiary of Orgentec Diagnostika GmbH is a medical device company that offers medical diagnostic solutions. The company offers vascular disease products, infectious disease products, non-invasive liver biomarkers, and instrumentation. It offers an instru …
  • Trinity Industries, Inc (TRN):電力:M&Aディール及び事業提携情報
    Summary Trinity Industries, Inc. (Trinity) is a diversified industrial company. It produces and supplies railcars and railcar parts, inland barges, aggregates and highway products. It also manufactures tank containers, steel parts and structural wind towers. It also offers services such as railcar f …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sembcorp Industries Ltd (U96):企業の財務・戦略的SWOT分析
    Sembcorp Industries Ltd (U96) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Marel hf:企業の戦略・SWOT・財務分析
    Marel hf - Strategy, SWOT and Corporate Finance Report Summary Marel hf - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Smiths Group plc:企業の戦略・SWOT・財務情報
    Smiths Group plc - Strategy, SWOT and Corporate Finance Report Summary Smiths Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • K’s Holdings Corporation:企業の戦略・SWOT・財務情報
    K's Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary K's Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fate Therapeutics Inc (FATE):企業の財務・戦略的SWOT分析
    Fate Therapeutics Inc (FATE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Epigenomics AG (ECX):製薬・医療:M&Aディール及び事業提携情報
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …
  • Atlas Genetics Ltd-医療機器分野:企業M&A・提携分析
    Summary Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposab …
  • The Whiting-Turner Contracting Co:企業の戦略・SWOT・財務情報
    The Whiting-Turner Contracting Co - Strategy, SWOT and Corporate Finance Report Summary The Whiting-Turner Contracting Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Symphony Ltd:企業の戦略・SWOT・財務情報
    Symphony Ltd - Strategy, SWOT and Corporate Finance Report Summary Symphony Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Teva Pharmaceuticals USA Inc:企業のM&A・事業提携・投資動向
    Teva Pharmaceuticals USA Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teva Pharmaceuticals USA Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • TRACON Pharmaceuticals Inc (TCON):医療機器:M&Aディール及び事業提携情報
    Summary TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TRC253, TRC694, and TRC205. Its lead product …
  • Adapt Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Adapt Pharma Ltd (Adapt Pharma) is a drug discovery and development company that manufactures and distributes prescription medicines. The company’s product Narcan (naloxone hydrochloride) nasal spray is an opioid antagonist that is indicated for the emergency treatment of opioid overdose as …
  • Slovenske elektrarne, a.s.:発電所・企業SWOT分析
    Slovenske elektrarne, a.s. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆